Unitedhealth (UNH) Stock
Major US health insurer and services provider. Here's the price, business snapshot, and what's worth knowing about Unitedhealth in November 2026.
UnitedHealth Group Incorporated (UNH) is one of the largest health insurers and healthcare services companies in the United States, combining health benefits with a fast-growing healthcare services arm (Optum). Investors should know it benefits from recurring revenue through insurance premiums and diversified fee-based services such as care delivery, pharmacy services and technology-enabled administration. The group’s scale supports margins and cash generation, but it operates in a highly regulated sector where policy changes, reimbursement pressures and litigation can affect results. With a market capitalisation of about $330.91B, UNH has a track record of steady cash flow, dividends and share buybacks, though past performance is not a guarantee of future returns. Suitable for investors who understand healthcare cycles and regulatory risk, it may not suit those seeking short-term, low-volatility holdings. This is general information and not personalised investment advice.
Why It’s Moving
UnitedHealth Boosts Outlook for Third Time as Optum Health Profits Surge
- Adjusted earnings per share guidance for 2026 was increased from at least $17.75 in January to at least $20.50 in October, reflecting improved financial performance.
- Optum Health reported $735 million in operating earnings for the third quarter, a substantial increase from $41 million in the same period last year.
- Profitability is rising despite fewer members and lower sales in certain segments, attributed to higher margins and strict pricing discipline.
UnitedHealth Boosts Outlook for Third Time as Optum Health Profits Surge
- Adjusted earnings per share guidance for 2026 was increased from at least $17.75 in January to at least $20.50 in October, reflecting improved financial performance.
- Optum Health reported $735 million in operating earnings for the third quarter, a substantial increase from $41 million in the same period last year.
- Profitability is rising despite fewer members and lower sales in certain segments, attributed to higher margins and strict pricing discipline.
Sixth Month Growth Performance
When is the next earnings date for UNITEDHEALTH GROUP INC (UNH)?
UNH has not yet announced a confirmed date for its next earnings report. Based on the historical pattern of reporting approximately three months after the previous release, the upcoming announcement is expected in January 2027. This forthcoming report will cover the fourth quarter and full-year results for fiscal 2026. Investors should monitor official company communications for the precise scheduling details as they become available.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying UnitedHealth Group's stock with a target price of $539.22, indicating strong potential growth.
Financial Health
UnitedHealth Group is performing well with strong revenue and cash flow, indicating healthy financial stability.
Dividend
UnitedHealth's dividend yield of 2.25% offers a modest return for dividend-seeking investors. If you invested $1000 you would be paid $22.50 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Steady cash flow
Insurance premiums and high-margin services provide predictable cash generation, though results can vary with claims experience and regulation.
Vertical integration focus
Optum’s mix of care, pharmacy and data is aimed at efficiency and growth, but execution and competition remain important risks.
Policy sensitivity
Legislation and regulatory decisions can materially affect revenue and margins, so investors should monitor policy developments.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
